Mead Johnson Nutrition Co, founded in 1905 and headquartered in Glenview, Illinois, is a leading global provider of pediatric nutrition products. The company's primary focus is on developing science-based nutritional solutions for infants and children, with a strong portfolio that includes well-known brands such as Enfamil and Nutramigen.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| RBLN 4.13% 2025-11-15 USDMead Johnson Nutrition Co | United States | 2025-11-15 | 4.125 | 15.53 |
| RBLN 4.60% 2044-06-01 USDMead Johnson Nutrition Co | United States | 2044-06-01 | 4.600 | 5.40 |
| RBLN 5.90% 2039-11-01 USDMead Johnson Nutrition Co | United States | 2039-11-01 | 5.900 | 5.11 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Mead Johnson began issuing bonds in the early 1990s to support its expanding operations and enhance liquidity. Notably, in 2017, the company issued $750 million in senior notes, which were primarily aimed at refinancing existing debt and funding growth initiatives. As of 2023, current yields on its bonds remain competitive within the industry, reflecting investor confidence and the company's strong market position. Recent news includes the strategic acquisition by Reckitt Benckiser, aiming to bolster its product offerings, which has influenced its bond dynamics positively.